View Post

Workaround erases side effects of promising cell-based cancer therapy

In In The News by Barbara Jacoby

By: Bruce Goldman Source: Stanford Medicine News Center Stanford scientists created an odd couple: a modified version of an immune-signaling protein and a coordinately modified receptor for this protein. The two bind only to each other, easing an advanced anti-cancer therapy’s side effects. Altering a powerful immune-signaling chemical plus its receptor on immune cells may bring a promising cancer treatment …

View Post

Hot flashes caused by cancer therapy can be prevented, treated

In In The News by Barbara Jacoby

By: Carolyn Crist From: reuters.com Cancer patients with hot flashes related to hormone therapy should know that these uncomfortable symptoms can be managed, according to a recently published resource for patients. “The goal of any therapy is to help patients feel better, and we don’t want them to needlessly suffer and think there are no treatments available,” said Dr. Arjun …

View Post

‘Double decker’ antibody technology fights cancer

In In The News by Barbara Jacoby

Source: Scripps Research Institute From: sciencedaily.com Scientists from the Florida campus of The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates (ADCs), using a versatile “double decker” technology that ties antibodies and a drug together to produce highly potent pharmaceuticals for cancer therapy. The new ADC technology advances a class of pharmaceuticals that use antibodies to …

View Post

Study Shows First Practical Intervention for Chemobrain

In In The News by Barbara Jacoby

SAN FRANCISCO, CA (October 31, 2016) – For the first time, symptoms of cancer-related cognitive decline – often called “chemobrain” –  were reversed in a large, home-based, randomized controlled trial, using unique computerized brain exercises, according to a report today in the Journal of Clinical Oncology. Breast cancer support groups first brought attention to a phenomenon they called “chemobrain” or …

View Post

Brazil president signs law legalizing renegade cancer pill

In In The News by Barbara Jacoby

By: Herton Escobar From: sciencemag.org Responding to political pressure and popular demand for a largely untested cancer drug, Brazilian President Dilma Rousseff signed into law today a measure that allows the renegade compound—synthetic phosphoethanolamine—to be produced and sold legally as a cancer therapy in Brazil. Scientists poured scorn on the decision, contending it puts patients at risk and undermines the …

View Post

UPDATE 1-Novartis broadens cancer immune therapy pipeline with acquisition, pacts

In In The News by Barbara Jacoby

From: reuters.com Novartis has broadened its immuno-oncology pipeline with the acquisition of Admune Therapeutics and through licensing agreements with small drug developers Xoma and Palobiofarma. Palobiofarma, a Spanish biotech company, said separately it entered into a $15 million licensing agreement with the Swiss group. Novartis said in a statement on Wednesday these transactions add Admune’s IL-15 agonist programme, Palobiofarma’s adenosine …

View Post

MRI scans can deliver cancer therapy

In In The News by Barbara Jacoby

By: Michelle Roberts From: bbc.com A hospital scan normally used to detect cancer could be used to steer tumour killing treatments to hard-to-reach targets in the body, say scientists. The UK team at Sheffield University deployed the magnetic power of MRI scans to control the movement of a specially designed injectable cancer therapy. Early trials in mice suggest the novel …

View Post

Could Oxygen Make Cancer Therapy Work Better?

In In The News by Barbara Jacoby

By: Maggie Fox From: nbcnews.com Researchers have been looking for years for a way to use oxygen to fight cancer. Now, they may finally have one. A new study finds that giving high-dose oxygen may help efforts to stimulate the immune system against tumors. The study’s only been done in mice and hasn’t been shown safe in people yet — …

View Post

Arming the Immune System Against Cancer

In In The News by Barbara Jacoby

By: Claudia Dreifus From: nytimes.com James P. Allison is the chairman of the immunology department at the University of Texas M.D. Anderson Cancer Center in Houston. His seminal research opened up a new field in cancer treatment: immunotherapy. Instead of poisoning a tumor or destroying it with radiation, Dr. Allison has pioneered ways to unleash the immune system to destroy …

A Breakthrough Bioelectronic Medical Approach to Cancer Treatment

In In The News by Barbara Jacoby

Cancer-Code Corporation (C3) announces the issuance of U.S. Patent No. 8,656,930 on February 25, 2014. The ‘930 patent, entitled “Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy,” covers a breakthrough technological approach to eradicating cancer in humans and animals. This is a foundation patent in the burgeoning field of bioelectronic medical applications, specifically for treating cancer …